BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20187731)

  • 41. Health literacy needs in weight management of women with Polycystic Ovary Syndrome.
    Lim S; Smith CA; Costello MF; MacMillan F; Moran L; Teede H; Ee C
    Health Promot J Austr; 2021 Feb; 32 Suppl 1():41-48. PubMed ID: 32323376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perspectives of Allied Health Professionals on Implementation of the Lifestyle Polycystic Ovary Syndrome Guidelines: A Qualitative Study.
    Moran LJ; Tan ZQ; Bayer S; Boyle JA; Robinson T; Lim SS
    J Acad Nutr Diet; 2022 Jul; 122(7):1305-1316. PubMed ID: 34800697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
    Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
    Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Noakes M; Clifton PM; Wittert GA; Belobrajdic DP; Norman RJ
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2944-51. PubMed ID: 17504892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial.
    Jiskoot G; Dietz de Loos A; Beerthuizen A; Timman R; Busschbach J; Laven J
    PLoS One; 2020; 15(6):e0233876. PubMed ID: 32479544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options.
    Moran L; Gibson-Helm M; Teede H; Deeks A
    J Psychosom Obstet Gynaecol; 2010 Mar; 31(1):24-31. PubMed ID: 20050767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implementation of the polycystic ovary syndrome guidelines: A mixed method study to inform the design and delivery of a lifestyle management program for women with polycystic ovary syndrome.
    Pirotta S; Joham AE; Moran LJ; Skouteris H; Lim SS
    Nutr Diet; 2021 Nov; 78(5):476-486. PubMed ID: 33876532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS).
    Herbert S; Woolf K
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A guide to understanding polycystic ovary syndrome (PCOS).
    Duncan WC
    J Fam Plann Reprod Health Care; 2014 Jul; 40(3):217-25. PubMed ID: 24591680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise therapy in polycystic ovary syndrome.
    Hoeger KM
    Semin Reprod Med; 2008 Jan; 26(1):93-100. PubMed ID: 18181087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Women's perceptions of polycystic ovary syndrome following participation in a clinical research study: implications for knowledge, feelings, and daily health practices.
    Colwell K; Lujan ME; Lawson KL; Pierson RA; Chizen DR
    J Obstet Gynaecol Can; 2010 May; 32(5):453-459. PubMed ID: 20500954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
    Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perceptions and experiences of lifestyle interventions in women with polycystic ovary syndrome (PCOS), as a management strategy for symptoms of PCOS.
    Arentz S; Smith CA; Abbott J; Bensoussan A
    BMC Womens Health; 2021 Mar; 21(1):107. PubMed ID: 33731099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success.
    Ee C; Pirotta S; Mousa A; Moran L; Lim S
    BMC Endocr Disord; 2021 Nov; 21(1):234. PubMed ID: 34814919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.
    Panidis D; Tziomalos K; Papadakis E; Vosnakis C; Chatzis P; Katsikis I
    Endocrine; 2013 Dec; 44(3):583-90. PubMed ID: 23625194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
    Alvarez-Blasco F; Botella-Carretero JI; San Millán JL; Escobar-Morreale HF
    Arch Intern Med; 2006 Oct; 166(19):2081-6. PubMed ID: 17060537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.